Evidence map›Paper›PMID 42337259›Full record

ArticleNature communications2026

Biophysical modeling for accurate T cell specificity prediction of viral and tumor antigens.

Zahra S Ghoreyshi, Noah Tubo, Luca Zammataro, Xizeng Mao, Ho Ngai, Duncheng Wang, Yibin Chen, Qiuming He, Eduardo Cisneros de la Rosa, Shoudan Liang and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Zahra S GhoreyshiDepartment of Biomedical Engineering, Texas A&M University, College Station, TX, USA.ORCID http://orcid.org/0009-0006-1097-5751
Noah TuboEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Luca ZammataroEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xizeng MaoEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ho NgaiEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Duncheng WangEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yibin ChenEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Qiuming HeEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eduardo Cisneros de la RosaBioinformatics Research Center, North Carolina State University, Raleigh, NC, USA.
Shoudan LiangEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Priya J KoppikarEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4966-5826
Xingcheng LinBioinformatics Research Center, North Carolina State University, Raleigh, NC, USA. xlin35@ncsu.edu.ORCID http://orcid.org/0000-0002-9378-6174
Jeffrey J MolldremEvolution of Cancer, Leukemia, and Immunity Post Stem cEll transplant (ECLIPSE), Strategic Research Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jmolldre@mdanderson.org.ORCID http://orcid.org/0000-0003-1196-1715
Jason T GeorgeDepartment of Biomedical Engineering, Texas A&M University, College Station, TX, USA. jason.george@tamu.edu.ORCID http://orcid.org/0000-0002-8248-2888

Funding

Quantifying phenotypic adaptation of biological systems in dynamic environmentsR35GM155458 · NIGMS · TEXAS ENGINEERING EXPERIMENT STATION · PI Jason George · 2024 to 2026
$1.1M
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR210080NIGMS NIH HHS R35 GM155458U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM155458
6 · The paper itself

Abstract

We develop and apply a dual experimental and computational framework to predict antigen specificity of TCR sequences in serial clinical samples. Our model integrates TCR primary sequences with previously reported and in silico-derived TCR-pMHC structural data. We apply this approach in the setting of hematopoietic stem cell transplant, focusing on a collection of HLA-A*02-restricted epitopes, including the Melan-A tumor associated antigen (ELAGIGILTV), Influenza A virus M1

Indexed as

Antigens, NeoplasmAntigens, ViralAntigens, Viral, TumorReceptors, Antigen, T-CellT-Cell Antigen Receptor SpecificityT-LymphocytesAmino Acid SequenceEpitopes, T-LymphocyteHLA-A2 AntigenHumansMART-1 AntigenPhosphoproteinsViral Matrix ProteinsAntigens, NeoplasmAntigens, ViralAntigens, Viral, Tumorcytomegalovirus matrix protein 65kDaEpitopes, T-LymphocyteHLA-A2 AntigenMART-1 AntigenMLANA protein, humanPhosphoproteinsReceptors, Antigen, T-CellViral Matrix Proteins

Identifiers

PMID42337259
PMCPMC13442875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.